Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis

MLA

Jingbo Lu, et al. “Impact of Genetic Polymorphisms in Thrombin Activatable Fibrinolysis Inhibitor (TAFI) on Venous Thrombosis Disease: A Meta-Analysis.” Gene, vol. 569, Sept. 2015, pp. 173–81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....56bfc66df0d941206cab97a8eccbcfcd&authtype=sso&custid=ns315887.

APA

Jingbo Lu, Zhengjun Liu, Hao Liu, Kai Qian, Zhiqi Lin, Heng Wan, Fang-Yong Fu, & Jie Xu. (2015). Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis. Gene, 569, 173–181.

Chicago

Jingbo Lu, Zhengjun Liu, Hao Liu, Kai Qian, Zhiqi Lin, Heng Wan, Fang-Yong Fu, and Jie Xu. 2015. “Impact of Genetic Polymorphisms in Thrombin Activatable Fibrinolysis Inhibitor (TAFI) on Venous Thrombosis Disease: A Meta-Analysis.” Gene 569 (September): 173–81. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....56bfc66df0d941206cab97a8eccbcfcd&authtype=sso&custid=ns315887.